03/11/25 -"Our EPS for 2025 and 2026 suffered from the integration of Imerys model update following Q2 results, which came in below our analyst expectations. This was partially offset in 2026 by a better ..."
Pages
63
Language
English
Published on
03/11/25
You may also be interested by these reports :
03/11/25
Our EPS for 2025 and 2026 suffered from the integration of Imerys model update following Q2 results, which came in below our analyst expectations. ...
03/11/25
GBL has announced a (less surprising) portfolio simplification with significant monetisation of its indirect private capital assets (GBL Capital). ...
31/10/25
Q3 revenues came in better than expected, but the company guided for a reduced range of growth for 2026. Yet several items underscore the ...
31/10/25
We upgraded our target price for Leonteq, accounting for better prospects across 2025-2027, mostly helped by stronger cost-efficiency and a more ...